Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Beta Drugs Ltd

Healthcare | Small Cap

Beta Drugs Ltd Health Insights
Health Score : 7.51Health Score : 7.51

Beta Drugs Ltd. shows a picture of strong financial health, marked by exceptional profitability and impressive growth. The company has a very stable foundation with very little reliance on debt. It is successfully expanding its sales and profits, indicating high demand for its services in the healthcare sector. However, a key area of concern is its operational efficiency. The company takes a long time to convert its inventory into sales and is particularly slow in collecting payments from its customers. This can tie up cash that could be used elsewhere. The future outlook points towards continued expansion, but its success will also depend on how it manages its day-to-day operations.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Beta Drugs Ltd Health Insights
Health Score : 7.51Health Score : 7.51

Beta Drugs Ltd. shows a picture of strong financial health, marked by exceptional profitability and impressive growth. The company has a very stable foundation with very little reliance on debt. It is successfully expanding its sales and profits, indicating high demand for its services in the healthcare sector. However, a key area of concern is its operational efficiency. The company takes a long time to convert its inventory into sales and is particularly slow in collecting payments from its customers. This can tie up cash that could be used elsewhere. The future outlook points towards continued expansion, but its success will also depend on how it manages its day-to-day operations.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

110.66

Neutral

Industry Median

36.13

Neutral
Overvalued

Small Cap Median

35.79

Overvalued

P/E RATIO

40.27

P/B RATIO

8.68

Highly Overvalued

Industry Median

6.08

Highly Overvalued
Highly Overvalued

Small Cap Median

6.08

Highly Overvalued

P/S RATIO

7908.46

Highly Overvalued

Industry Median

5.75

Highly Overvalued
Highly Overvalued

Small Cap Median

5.17

Highly Overvalued

Others

Neutral

PEG RATIO

1.09

Neutral
Overvalued

EV/EBITDA RATIO

21.93

Overvalued

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 10.00

The company is experiencing an exceptional period of growth across all key areas. It is successfully increasing its revenues, profits, and asset base at a very impressive rate. This demonstrates strong market demand, effective business strategy, and a solid foundation for future expansion. This robust growth is a primary strength, indicating the company is performing very well in its market and is on a strong upward trajectory.

ExcellentRevenue Growth RateExcellent
ExcellentOperating Profit Growth RateExcellent
ExcellentEarnings Per Share (EPS) GrowthExcellent
ExcellentAsset Growth RateExcellent
ExcellentNet Income Growth RateExcellent
Growth RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue Growth Rate58.6223.3730.422.36.35
Operating Profit Growth Rate7223.2613.21251.33
Earnings Per Share (EPS) Growth111.923.7618.6116.46-2.62
Asset Growth Rate33.925.3228.2871.6513.76
Net Income Growth Rate108.332416.1316.67-2.38
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 6.80

From a shareholder's perspective, the company's financial metrics are strong, with high and growing earnings and book value per share. This indicates the underlying value of the company is increasing. However, the company is not providing a direct return to shareholders through dividends, as it is reinvesting all its profits. It is also spending significantly on capital expenditures to fuel its expansion, which is a long-term investment.

ExcellentAdjusted Earnings Per Share (Adjusted EPS)Excellent
ExcellentCash Earnings Per Share (Cash EPS)Excellent
ExcellentBook Value Per ShareExcellent
PoorDividend Per Share (DPS)Poor
PoorCapital Expenditures (CapEx)Poor
Financial RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Adjusted Earnings Per Share (Adjusted EPS)25313645.3741
Cash Earnings Per Share (Cash EPS)3241465558
Book Value Per Share93123158197245
Dividend Per Share (DPS)00000
Capital Expenditures (CapEx)19.418.211.636.9
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 10.00

The company's ability to generate profit is excellent across all measures. It is highly effective at converting revenue into profit at the gross, operating, and net levels. Furthermore, it delivers very strong returns on the assets it owns, the capital it employs, and the equity invested by its shareholders. This all-around profitability is a major strength and indicates a highly efficient and successful business model.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
ExcellentReturn on Assets (ROA)Excellent
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Profit Margin19.5718.9416.8917.1315.32
Return on Capital Employed (ROCE)3634332719
Return on Equity (ROE)26.8825.222.7821.3216.73
Return on Assets (ROA)27.2226.7723.6217.215.32
Operating Margin23.3723.3520.2720.7219.74
Net Margin13.5913.6612.1611.610.65
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.67

This is the company's most significant area of challenge. While financially stable, its day-to-day operations show signs of inefficiency. The company is slow in selling its products and is particularly slow in collecting payments from its customers. This means a lot of its capital is tied up in inventory and unpaid bills. Furthermore, it is not generating as much revenue as it could from its assets and overall capital investments, which could limit its full growth potential.

WeakFixed Asset Turnover RatioWeak
AverageInventory Turnover RatioAverage
WeakReceivables Turnover RatioWeak
WeakDays Sales in Inventory RatioWeak
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Fixed Asset Turnover Ratio3.353.64.554.073.08
Inventory Turnover Ratio7.796.946.075.474.87
Receivables Turnover Ratio4.664.24.173.983.47
Days Sales in Inventory Ratio46.8552.5960.1366.7374.95
Receivable Days78.3386.987.5391.71105.19
Capital Turnover Ratio1.691.691.761.11.02
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.80

The company's financial position allows it to comfortably cover its interest payments on debt, which is a strong positive sign of financial health. This reduces the risk associated with its borrowings. On the other hand, the company currently does not pay dividends to its shareholders. This suggests a strategy of retaining all earnings to fuel its significant growth and expansion plans, rather than distributing profits.

ExcellentInterest Coverage RatioExcellent
PoorEquity Dividend Coverage RatioPoor
Coverage RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Interest Coverage Ratio1821.517.339.144.6
Equity Dividend Coverage Ratio
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.00

The company's long-term financial stability is excellent. It has a very low-risk profile because it finances its operations primarily through owner's funds rather than borrowing. This minimal reliance on debt means the company is well-insulated from financial risks related to interest rate changes and has a strong capacity to take on new debt for future growth if needed. Overall, its balance sheet is exceptionally strong and stable.

GoodDebt RatioGood
ExcellentDebt to Equity RatioExcellent
GoodEquity RatioGood
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debt Ratio0.150.080.060.40.35
Debt to Equity Ratio0.180.090.060.670.54
Equity Ratio0.850.920.940.60.65
Debt To Asset Ratio0.10.060.040.30.27
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 8.38

The company's ability to cover its short-term financial obligations is very strong. It holds a healthy amount of current assets, including cash, relative to its immediate liabilities, which reduces the risk of short-term cash flow problems. A positive aspect is its capacity to pay bills even without selling inventory. A potential concern is that the cash generated directly from its core business operations is comparatively low, suggesting it may rely on other financial activities to maintain its cash position.

ExcellentCurrent RatioExcellent
ExcellentQuick RatioExcellent
GoodCash RatioGood
WeakOperating Cash Flow RatioWeak
Liquidity RatiosMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Current Ratio2.042.112.183.243.17
Quick Ratio1.61.621.612.682.54
Cash Ratio0.340.30.331.371.07
Operating Cash Flow Ratio0.60.360.360.340
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 10 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Jagsonpal Pharmaceuticals Ltd8.5133.01Overvalued58.006.4243.00
2Amrutanjan Health Care Ltd8.2577.37Highly Overvalued31.0020.0321.00
3Windlas Biotech Ltd7.5225.92Neutral105.0032.1966.00
4Beta Drugs Ltd7.5140.27Neutral76.0013.7641.00
5Syncom Formulations (India) Ltd6.9217.27Undervalued77.000.8176.00
6Hester Biosciences Ltd6.5431.74Neutral87.0061.2457.00
7Sigachi Industries Ltd6.4911.55Highly Undervalued54.00-2.08-83.00
8SMS Pharmaceuticals Ltd5.9434.77Neutral171.009.35102.00
9Tarsons Products Ltd5.9097.63Neutral118.004.2614.00
10Shalby Ltd5.8549.37Undervalued143.0010.4535.00
Management Assessment Summary
OrangeBalanced Management

Management demonstrates mixed effectiveness. Strengths are rooted in a strong historical growth track record, stable operating margins, and a robust shareholding structure with high promoter conviction and increasing institutional interest. However, significant concerns arise from recent and forward-looking data. Key weaknesses include a sharp deceleration in sales and profit growth, with TTM profit growth turning negative. Capital efficiency is deteriorating, as evidenced by declining ROCE and a worsening cash conversion cycle. The most critical issue is a projected massive increase in debt, which significantly alters the company's previously conservative financial profile. The combination of past strengths with current and future weaknesses warrants a cautious, mixed assessment.

Category Metric Value Assessment
PROS Strong Promoter Holding 64.63% strong
Increasing Institutional Holding FII: 1.16%, DII: 2.15% improving
Stable Operating Profit Margins ~20% stable
Strong 5Y Compounded Sales Growth 27% strong
CONS Declining TTM Profit Growth -9% weak
Projected Surge in Borrowings ₹15 Cr to ₹148 Cr poor
Deteriorating Return on Capital ROCE from 36% to 19% declining
Worsening Cash Conversion Cycle 100 Days weak
WeakFinancial Performance & GrowthWeak
WeakCapital Efficiency & ReturnsWeak
PoorFinancial Health & PrudencePoor
ExcellentShareholding & Ownership StructureExcellent
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Shareholding & Ownership Structure

Risk Assessment Summary
RedWeak Risk

The overall risk profile is high due to a convergence of significant financial and operational risks. The most prominent risk is the sharp, projected increase in financial leverage. A nearly tenfold rise in borrowings significantly increases the company's vulnerability to economic downturns and interest rate hikes, as reflected in the rapidly declining interest coverage ratio. This financial strain is compounded by deteriorating operational performance, including a marked slowdown in growth, negative profit trends, and weakening working capital efficiency. The combination of taking on substantial debt while core business performance is faltering creates a high-risk scenario. The strong shareholding pattern provides some stability but does not mitigate the immediate and substantial financial and operational risks.

PoorAccounting quality red flagsPoor
PoorForeign exchange or interest rate exposurePoor
01.

Accounting quality red flags

02.

Foreign exchange or interest rate exposure

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Hour Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 2 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 4 Hours Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Day Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Week Timeframe

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 1 Technical Indicators From The 1 Month Timeframe